aminoglycoside

(redirected from Aminoglycosides)
Also found in: Medical.
Related to Aminoglycosides: Macrolides, Aminoglycoside antibiotics

a·mi·no·gly·co·side

 (ə-mē′nō-glī′kə-sīd′, ăm′ə-)
n.
Any of a group of broad-spectrum antibiotics, such as streptomycin, derived from species of Streptomyces or Micromonospora bacteria and used to treat infections caused by gram-negative bacteria.
Mentioned in ?
References in periodicals archive ?
Only 17/46 (37%) of the subjects who received aminoglycosides had a mildly reduced eCCL, compared with 5/10 (50%) of the subjects who received no antibiotic treatment.
Aminoglycosides, amphotericin B, prostaglandins, cisplatin, and heavy metals have been reported to be associated with Bartter-like syndrome [2, 3].
We found a high prevalence and coexistence of genes encoding quinolone and aminoglycosides resistance that were heterogenous and mostly clonally unrelated.
Gentamicin is one of the most commonly used aminoglycosides against enterococcus, since its discovery in 1963.
Aminoglycosides are used either alone or in combination with [beta]-lactams as effective agents for treating such infections (1).
Among the most powerful weapons in our antibiotic arsenal are aminoglycosides, which can prevent the biosynthesis of key proteins that infectious bacteria such as Staphylococcus aureus and Escherichia coli need to survive.
Although high concentrations of aminoglycosides, despite the use of standard doses corrected for Cr-based GFR estimates, may indicate renal impairment, this is akin to shutting the stable door long after the horse has gone.
Aminoglycosides are a broad-spectrum class of Gram-negative antibiotics that are a mainstay in the hospital setting.
We evaluated the ototoxic effect of aminoglycosides on the outer hair cells of newborns in a neonatal intensive care unit (NICU) by means of distortion-product otoacoustic emissions (DPOAE) testing.
Aminoglycosides, which include streptomycin and gentamicin, are widely used to treat serious infections and sepsis, a deadly condition marked by the immune system going into overdrive.
Background: Enterobacteriaceae, common pathogens responsible for urinary tract infections are known to be susceptible to aminoglycosides. The emergence of resistant pathogens complicates antimicrobial regimen and becomes a challenge for clinicians.